India's Sun Pharmaceutical has agreed to acquire rival Ranbaxy - majority owned by Japan's Daiichi Sankyo - in an all-stock deal worth $4bn (£2.4bn).
Showing posts with label Indian manufacturing units. Show all posts
Showing posts with label Indian manufacturing units. Show all posts
Subscribe to:
Posts (Atom)